Clinical Trial Update: Tack Optimized Balloon Angioplasty Post-Market Study

View source ↗

Summary

The post-market study evaluating the Tack Optimized Balloon Angioplasty device for peripheral arterial disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Tack Optimized Balloon Angioplasty

Snippet

Sponsor: Spectranetics Corporation | Conditions: PAD - Peripheral Arterial Disease, PAD | Status: TERMINATED